| 1 |
33443933 | Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo. | 2021 Apr 1 |
1 |
| 2 |
30451372 | Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay. | 2019 Jan |
3 |
| 3 |
30575685 | Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner. | 2019 Jan |
3 |
| 4 |
22918041 | Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator. | 2012 Dec |
2 |
| 5 |
22974122 | Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator. | 2012 Nov |
2 |
| 6 |
18460030 | Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. | 2008 Jul |
1 |
| 7 |
9117184 | Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis. | 1997 Jan |
1 |
| 8 |
9275473 | [The role of urokinase type plasminogen activator in invasion of bile duct carcinoma]. | 1996 Aug |
1 |